 ?您的位置：對(duì)照品 > 對(duì)照品 > 雜質(zhì)對(duì)照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G797705 |
| 產(chǎn)品名稱：GSK 461364 |
| 產(chǎn)品CAS：929095-18-1 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797705 |
| 名稱: |
GSK 461364 |
| 別名: |
5-[6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl]-3-[[(1R)-1-[2-(trifluoromethyl)phenyl]ethyl]oxy]thiophene-2-carboxamide; GSK 461364A; |
| CAS號(hào): |
929095-18-1 |
| 分子式: |
C??H??F?N?O?S |
| 分子量: |
543.6 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as an apoptotic agent at higher dosage levels. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
